Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.

Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.

Item
http://www.wikidata.org/entity/Q45421316
Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein.Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodiesIdentification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120.Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins.Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination.Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunizationDissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens.Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responsesIncreased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma virusesDevelopment and characterization of an equine infectious anemia virus Env-pseudotyped reporter virusA monoclonal antibody against lymphocyte function-associated antigen-1 decreases HIV-1 replication by inducing the secretion of an antiviral soluble factor.Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines
P2860

Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.

Item
http://www.wikidata.org/entity/Q45421316
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Neutralization and infectivity ...... eactive neutralizing activity.
@en
Neutralization and infectivity ...... eactive neutralizing activity.
@nl
type
label
Neutralization and infectivity ...... eactive neutralizing activity.
@en
Neutralization and infectivity ...... eactive neutralizing activity.
@nl
prefLabel
Neutralization and infectivity ...... eactive neutralizing activity.
@en
Neutralization and infectivity ...... eactive neutralizing activity.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Neutralization and infectivity ...... eactive neutralizing activity.
@en
P2093
P304
P31
P356
10.1016/J.VIROL.2005.11.019
P407
P433
P478
P577
P5875
P698